Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 30;28(1):5-11.
doi: 10.1016/j.joco.2016.01.008. eCollection 2016 Mar.

Erythropoietin in ophthalmology: A literature review

Kaveh Abri Aghdam  1 , Mostafa Soltan Sanjari  1 , Khalil Ghasemi Falavarjani  2
Affiliations
Review

Erythropoietin in ophthalmology: A literature review

Kaveh Abri Aghdam et al. J Curr Ophthalmol. .

Abstract

Purpose: To review the current literature on ocular application of erythropoietin (EPO).

Methods: A comprehensive search was performed on Pubmed and Scopus databases. All selected articles were reviewed thoroughly by the authors to review current applications of the EPO in ocular diseases.

Results: Various aspects of administration of EPO for different ischemic, traumatic, vascular, and degenerative disorders have been explained. The articles are generally preclinical with few small studies reporting clinical outcomes.

Conclusion: EPO has been used for the treatment of different ophthalmic conditions with promising results. Further studies are needed to elaborate the role of EPO in management of ocular diseases.

Keywords: Apoptosis; Erythropoietin; Neuroprotection.

PubMed Disclaimer

References

    1. Genc S., Koroglu T.F., Genc K. Erythropoietin and the nervous system. Brain Res. 2004;1000:19–31. - PubMed
    1. Fried W., Kilbridge T., Krantz S., McDonald T.P., Lange R.D. Studies on extrarenal erythropoietin. J Lab Clin Med. 1969;73:244–248. - PubMed
    1. Chang Z.Y., Yeh M.K., Chiang C.H., Chen Y.H., Lu D.W. Erythropoietin protects adult retinal ganglion cells against NMDA-, trophic factor withdrawal-, and TNF-α-induced damage. PLoS One. 2013;8(1):e55291. - PMC - PubMed
    1. Bogoyevitch Marie A. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc Research. 2004;63:208–216. - PubMed
    1. Alural B., Duran G.A., Tufekci K.U. EPO mediates neurotrophic, neuroprotective, anti-oxidant, and anti-apoptotic effects via downregulation of miR-451 and miR-885-5p in SH-SY5Y neuron-like cells. Front Immunol. 2014;5:475. - PMC - PubMed

LinkOut - more resources